Skip to main content
. 2015 Dec 15;7(12):389–400. doi: 10.4251/wjgo.v7.i12.389

Table 1.

Pre-operative chemotherapy in non-resectable gastric cancer

Ref. Regimen No. patients Stage R0 resection (%) Median survival (mo)
Wilkie et al[8] EAP 34 NR 44 24
Plukker et al[9] 5-FU + MTX 20 NR 40 22
Rougier et al[10] 5-FU, P 30 NR 60 16
Kelsen et al[11] FAMTX, IP 5FU-P 56 NR 61 15
Melcher et al[12] ECF 27 R-NR 58 (R pts) 10 (NR pts) 10
Gallardo-Rincón et al[13] P-ELF 60 NR 8,7 10
Cascinu et al[14] EAFPLG 82 NR 45 17

NR: Non-resectable; EAP: Etoposide, doxorubicin, cisplatin; IP: Intraperitoneal; ECF: Epirubicin, cisplatin, 5-FU; R: Resectable; P-ELF: Cisplatin, etoposide, leucovorin, 5FU; EAPFLG: Epi-doxorubicin, 5-FU, cisplatin, leucovorin, glutathione; 5-FU: 5-fluorouracil.